The clinical significance of comprehensive genomic profiling (ID 1796)
Generating meaningful evidence with novel trial designs and real-world data (ID 1797)
South Korea’s journey with precision oncology (ID 1798)
Singapore’s journey with precision oncology (ID 1799)
Q&A and closing remarks (ID 1800)